You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 24, June 27, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Relationship Between Postmenopausal Hormone Replacement Therapy and Ovarian Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Rodriguez and colleagues1 found a direct association between the use of hormone replacement therapy (HRT) and the risk of ovarian cancer. Data from other cohort and case-control studies, however, are less consistent.2

To further explore this issue, we updated the analysis of a collaborative reanalysis of European case-control studies of ovarian cancer.3 The present analysis study included 2501 women with histologically confirmed epithelial ovarian cancer and 5882 controls enrolled in 5 case-control studies: 2 were conducted in Greece, 1 in the United Kingdom, and 1 in Italy between 1979 and 1991, all previously reported,3 plus another case-control study conducted in 4 Italian locations between 1992 and 1999.4

The 5 original datasets were combined in a uniform format that included comparable variables, such as age, socioeconomic level, parity, oral contraceptive use, menopausal status, type of menopause, age at menopause, as well as HRT use, duration of use, . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Estrogen Replacement Therapy and Ovarian Cancer Mortality in a Large Prospective Study of US Women
Carmen Rodriguez, Alpa V. Patel, Eugenia E. Calle, Eric J. Jacob, and Michael J. Thun
JAMA. 2001;285(11):1460-1465.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis
Greiser et al.
Hum Reprod Update 2007;13:453-463.
ABSTRACT | FULL TEXT  

Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer
Glud et al.
Arch Intern Med 2004;164:2253-2259.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.